More on BDTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Black Diamond Therapeutics (NQ:BDTX)
Delayed: 1.96 -0.14 (6.67%)
Prev. Close $2.10  
Open$2.06 
52 Wk High$0.01 
52 Wk Low$0.01 
Day High$2.06 
Day Low$1.92 
P/E N/A  
EPS$0.00 
Volume675,701 

Friends, Peers and Foes (?): HNSBF, NUVB, PYXS, RIGL, RLMD (more...)

Sep 2, 2026 04:01 PM Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Aug 6, 2026 09:12 AM TD Cowen Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Aug 6, 2026 09:11 AM Jefferies Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Aug 6, 2026 09:11 AM Raymond James Reiterates Outperform Rating on Black Diamond Therapeutics (BDTX)
Aug 6, 2026 09:10 AM Stifel Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Aug 5, 2026 04:05 PM Form 10-Q Black Diamond Therapeuti For: Jun 30
Aug 5, 2026 04:02 PM Form 8-K Black Diamond Therapeuti For: Aug 05
Aug 5, 2026 04:01 PM Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Jul 27, 2026 04:27 PM Form SCHEDULE 13G Black Diamond Therapeuti Filed by: BlackRock, Inc.
Jul 8, 2026 11:31 AM Form SCHEDULE 13G/A Black Diamond Therapeuti Filed by: T. Rowe Price Investment Management, Inc.
View All Articles

Entities mentioned with BDTX

View All Entities